Clinical Management of Infectious Diseases Syndromes
Core concepts
Approach each syndrome by site, host, and likely pathogen. Know empiric regimens and when to narrow. Key syndromes: community-acquired pneumonia (CAP), hospital-acquired/ventilator-associated pneumonia (HAP/VAP), urinary tract infection (cystitis vs. pyelonephritis), intra-abdominal infection (source control is essential), skin and soft tissue infection (purulent vs. non-purulent), infective endocarditis (native vs. prosthetic), meningitis, sepsis/septic shock (early antibiotics and source control), and bloodstream infection (catheter-related vs. secondary). Understand when combination therapy is indicated (e.g., empiric double coverage for Pseudomonas in severe illness, though routine use is debated) and when it is not. Recognize the role of source control (drainage, debridement, device removal) as a determinant of cure.
Traps
- Treating asymptomatic bacteriuria.
- Using a single drug for a syndrome requiring anaerobic or atypical coverage.
- Delaying antibiotics in septic shock while awaiting cultures.
- Missing the need for device removal in catheter-related bloodstream infection or prosthetic valve endocarditis.
Rule of thumb
For any severe infection, ask two questions: Is the antibiotic spectrum adequate, and has the source been controlled?
Worked example: A patient with intra-abdominal abscess and sepsis: start broad-spectrum antibiotics with anaerobic coverage and arrange drainage; antibiotics alone may fail without source control.